HCID 18689941, 화합물 → HCID 15462193, 화합물

HRID 1871927노트

반응식

HRID 1871927 반응식
Cl[CH2:2][CH2:3][CH2:4][O:5][C:6]1[CH:14]=[CH:13][C:12]([CH3:15])=[C:11]2[C:7]=1[C:8]([CH3:18])([CH3:17])[C:9](=[O:16])[NH:10]2.[N:19]1[C:28]2[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=2)[CH:22]=[CH:21][C:20]=1[CH2:29][CH:30]1[CH2:35][CH2:34][NH:33][CH2:32][CH2:31]1>>[N:19]1[C:28]2[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=2)[CH:22]=[CH:21][C:20]=1[CH2:29][CH:30]1[CH2:31][CH2:32][N:33]([CH2:2][CH2:3][CH2:4][O:5][C:6]2[CH:14]=[CH:13][C:12]([CH3:15])=[C:11]3[C:7]=2[C:8]([CH3:18])([CH3:17])[C:9](=[O:16])[NH:10]3)[CH2:34][CH2:35]1

참가 물질

3

반응물 2

HCID 18689941HCID 18689941, 화합물HCID 232910814-(3-Chloropropoxy)-3,3,7-trimethyl-2,3-dihydro-1H-indol-2-one

생성물 1

HCID 15462193HCID 15462193, 화합물

실험 절차

In a manner similar to that described in Example 1, 4-(3-chloropropoxy)-3,3,7-trimethyl-2,3-dihydro-1H-indol-2-one (268 mg) and 4-(2-quinolylmethyl)piperidine (226 mg) were processed, to thereby obtain the title compound as white powder.

출처 및 근거

ORD 기록
ord-ac695ef8836d445a8e789d76fe57faa6
출처 데이터셋
uspto-grants-2000_08
특허 번호
US06107308

반응 노트

불러오는 중…